• Thu news: Industry M&A volume down 8% over 2023. Pfizer’s Ibrance improves breast cancer survival. Lonza shedding capsule biz. AZ’s Lynparza in early breast cancer. Trump wants childhood vaccine discussion. See more on our front page

All is great, things could not be better







With all the negativity on this site, it’s nice to see a positive comment here. Apyx, formerly Bovie, is and has been a wonderful place to work. I’ve seen good and I’ve seen bad, and other than a car allowance that’s not representative of what a great job this is, this is as good as it gets in the industry. Doing the math on the sales numbers, the top 15-20% of the reps made 300+ last year.

I’m laughing to myself thinking about how the CafePharma crowd historically shreds posts like this. I should add that I’m not a manager, just a very satisfied rep.
 












This company is a joke. $24 Million in Revenue with a $14 Million loss and they pay Charlie $1.4M. What type of a company operates like this? A total house of cards! He is a total idiot that drives company profits down.